Waters Corp at JPMorgan Healthcare Conference Transcript
All right. Great. Welcome to JPMorgan Healthcare Conference.
I'm Casey Woodring from the Life Science Tools & Diagnostics team. Pleased to be joined by Waters' CEO, Udit Batra.
Udit is going to go through the corporate presentation. And then, we'll leave some time at the end for Q&A. Udit, all you.
Thank you, Casey. Good afternoon, everyone.
Roughly five years ago, we started a transformation process that has led to an increase in our commercial strength, revitalization of innovation, and entry into fast-growing adjacencies for Waters. That has then allowed us to make the acquisition of BD's Biosciences and Diagnostics business.
Today, I'll talk to you a bit about how we're executing from a position of strength; with the acquisition of BD's Biosciences and Diagnostics business, how we see the next few years for value creation for our corporation; and, finally, I'll give you a bit of a hint on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

